• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home StudyGraphics

#VisualAbstract: Effectiveness of stand-alone telephone-delivered intervention for reducing problem alcohol use

byMinjee Kim
October 6, 2022
in StudyGraphics
Reading Time: 3 mins read
#VisualAbstract: Dapagliflozin slows disease progression in patients with heart failure with preserved ejection fraction
Share on FacebookShare on TwitterShare on LinkedIn

1. In this randomized controlled trial, in participants with problem alcohol use, individuals in the active control group, receiving brief check-ins, and the intervention group, receiving telehealth cognitive and behavioural interventions, both experienced a significant decrease in alcohol use severity 3 months after randomization. 

2. The intervention group showed a significantly greater reduction in alcohol use than the active control group.

Evidence Rating Level: 1 (Excellent)

Alcohol use is a leading cause of preventable morbidity and mortality, but there is a sharp contrast between its prevalence and the use of alcohol treatments. This treatment gap is attributable to the multiple individual and structural barriers that exist, and especially since the pandemic, access to treatment has been further disrupted. Telehealth has the potential to overcome many of the barriers to accessing treatment and has been previously studied in smoking cessation with great success. There is a lack of high-quality evidence surrounding telehealth in the treatment of alcohol use disorders, and the purpose of this single-site, double-blind, parallel-group randomized controlled trial was to examine the effectiveness of a telephone-delivered treatment, Ready2Change, in reducing alcohol use in patients with alcohol use problems. Participants 18 years or older with problem alcohol use (as per the Alcohol Use Disorders Identification Test (AUDIT) score), were recruited from Australia using social media between May 2018 and October 2019. Participants were randomized in a 1:1 ratio to the intervention group or control group. The intervention group received 4-6 sessions of telephone-delivered intervention, while the active control group received 4 telephone check-ins from a researcher. The primary outcome was a change in alcohol problem severity at 3 months after baseline, using the AUDIT score. 344 participants were included in the study, with 173 patients (50.3%) assigned to the intervention group, and 171 participants (49.7%) assigned to the active control group. With respect to the primary outcome, there was a significant difference in the AUDIT score for the treatment group when compared to the active control group at 3 months (difference, -2.15; 95% CI, -3.64 to -0.65; P=.005). There were no significant treatment-by-time interactions observed between the two groups. In both groups, there was a significant decrease in total AUDIT score from baseline to 3 months (P<.001). A major limitation of this study was that the active control group experienced a significant reduction in alcohol use, which was greater than anticipated; future studies should consider this possibility and adjust their trial accordingly. Overall, the findings from this trial did not suggest the superior effectiveness of the intervention when compared to the active control, as both groups experienced a significant decrease in AUDIT score between baseline and three months. However, the intervention group showed a greater reduction in AUDIT score at 3 months relative to the active control group. The results of this trial support benefits of a telephone-delivered intervention, which may reduce the treatment gap for problem alcohol use in the general population.

Click to read the study in JAMA Psychiatry

RELATED REPORTS

Alcohol use declines but remains above pre-pandemic levels

Deficits in executive function are not universal among patients with alcohol use disorder

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alcoholalcohol usealcohol use disorderalcohol use disorders identification test (AUDIT)AUDIT scorebehavioral interventioncognitive behavioral therapy (CBT)Ready2Changetelehealthtelephone check-in
Previous Post

Stereotactic body radiation does not improve outcomes in patients with advanced Merkel cell carcinoma receiving nivolumab and ipilimumab

Next Post

Wellness Check: Nutrition

RelatedReports

A healthcare professional examines a complex network of decision paths and technology symbols, representing the integration of AI in clinical diagnostics and decision-making.
Psychiatry

Alcohol use declines but remains above pre-pandemic levels

September 22, 2026
An illustration featuring healthy food, light therapy, exercise, and a patient consultation, emphasizing various aspects of wellness in mental health.
Chronic Disease

Deficits in executive function are not universal among patients with alcohol use disorder

September 15, 2026
A person walks across a bridge connecting two buildings, one symbolizing mental health (head silhouette) and the other representing care (heart symbol).
Chronic Disease

Few interventions improve posthospitalization follow-up for alcohol use disorder

September 14, 2026
An illustration depicting telemedicine services connecting two hospitals through a digital interface, emphasizing interhospital transfer and remote healthcare delivery.
Chronic Disease

Video mental health care may have clinical advantages versus phone or in-person visits

September 12, 2026
Next Post
Provision of medically-tailored meals linked with lower admissions and medical spending

Wellness Check: Nutrition

#VisualAbstract: Cefepime and Enmetazobactam in treatment of urinary tract infection or acute pyelonephritis was more effective than Piperacillin and Tazobactam

#VisualAbstract: Cefepime and Enmetazobactam in treatment of urinary tract infection or acute pyelonephritis was more effective than Piperacillin and Tazobactam

Children’s hospital visits for suicide ideation and attempts are increasing

Ketamine use demonstrates promise for treatment-resistant depression

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A community health initiative in low-income areas may reduce hospital admission rates
  • Induction with remimazolam (Byfavo) for patients undergoing laparoscopic gastrointestinal surgery may reduce post-operative delirium compared with propofol
  • 2 Minute Medicine Rewind October 19, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.